Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹18 Cr₹18 Cr₹10 Cr₹6.17 Cr₹2.00 Cr

What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS is ₹18 Cr based on Mar2025 Standalone results.
Year Contingent Liabilities
Mar2025₹18 Cr
Mar2024₹18 Cr
Mar2023₹10 Cr
Mar2022₹6.17 Cr
Mar2021₹2.00 Cr

How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹18 Cr
-0.06
Mar2024 ₹18 Cr
67.43
Mar2023 ₹10 Cr
69.85
Mar2022 ₹6.17 Cr
208.45
Mar2021 ₹2.00 Cr -

Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹343.7 Cr 30.6% 29.7% 93.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

30.6%

29.7%

93.5%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses